November’s strong rally caught many investors by surprise after a weak October, turning many of the funds that were at the bottom of the pile into winners, and pushing former high performers into the list of laggards. A Biden win in the US election and perhaps more importantly, a flurry of positive announcements on a coronavirus vaccine, pushed investors into bullish mode.
“Who would have guessed at the start of 2020 that the biggest driver of global markets in November would have been news of virus vaccines and more importantly the efficacy of them?,” says Ben Yearsley, director at Shore Financial Planning. “How many people at the start of the year had ever used the word efficacy? The announcements by Pfizer, Moderna and AstraZeneca turbo charged markets, even though widespread vaccinations won’t occur until well into 2020.” (source)
Long Only Funds
| Rank | Company | Fund Name | August ’20 | YTD | CAGR | 3 Years | AUM (Million $) |
|---|
(Criteria used: Track Record > 1 Year, Currency: $US dollar, AUM > $100m)
ETFs
| Rank | Company | Fund Name | August ’20 | YTD | CAGR | 3 Years | AUM (Million $) |
|---|
(Criteria used: Track Record > 1 Year, Currency: $US dollar, AUM > $100m)
UCITS Funds
| Rank | Company | Fund Name | August ’20 | YTD | CAGR | 3 Years | AUM (Million $) |
|---|
(Criteria used: Track Record > 1 Year, Currency: $US dollar, AUM > $100m)
Fund of Funds
| Rank | Company | Fund Name | August ’20 | YTD | CAGR | 3 Years | AUM (Million $) |
|---|
(Criteria used: Track Record > 1 Year, Currency: $US dollar, AUM > $100m)
With vaccine news signalling that there is light at the end of the tunnel, uncertainty around the length of the Covid-19 crisis is beginning to fade, which in turn is brightening the outlook for risk assets – despite the difficult winter ahead for the economy. Within equities, the outperformance this month of this year’s losers makes sense, with a return to normality now on the horizon. As the economic recovery plays out, earnings expectations should continue to recover providing continued support for equities. For those seeking diversification beyond equities, we think that considering an allocation to flexible fixed income strategies and macro funds, as well as real assets, makes sense. (source)
Would you like to run your own analysis and view over 150k in-depth Fund Profiles?
Stay safe,
The Edgefolio team
Access the in-depth analysis to view additional measures for this fund group, including relative measures, historical absolute returns, risk and reward analysis and more. You can analyse each of the funds in this group and customise your own fund comparisons on Edgefolio.com. To find out more, contact us for a demo. Sign up to our newsletter for further updates like this from our blog.
Disclaimer
Data provided by Morningstar. Care has been taken to ensure that the information is correct, but Edgefolio neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.